Cargando…
CMV seropositivity is a potential novel risk factor for severe COVID-19 in non-geriatric patients
BACKGROUND: COVID-19 has so far affected more than 250 million individuals worldwide, causing more than 5 million deaths. Several risk factors for severe disease have been identified, most of which coincide with advanced age. In younger individuals, severe COVID-19 often occurs in the absence of obv...
Autores principales: | Weber, Simone, Kehl, Victoria, Erber, Johanna, Wagner, Karolin I., Jetzlsperger, Ana-Marija, Burrell, Teresa, Schober, Kilian, Schommers, Philipp, Augustin, Max, Crowell, Claudia S., Gerhard, Markus, Winter, Christof, Moosmann, Andreas, Spinner, Christoph D., Protzer, Ulrike, Hoffmann, Dieter, D’Ippolito, Elvira, Busch, Dirk H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9132318/ https://www.ncbi.nlm.nih.gov/pubmed/35613127 http://dx.doi.org/10.1371/journal.pone.0268530 |
Ejemplares similares
-
Phantosmia, Parosmia, and Dysgeusia Are Prolonged and Late-Onset Symptoms of COVID-19
por: Schambeck, Sophia E., et al.
Publicado: (2021) -
Predictors of CMV Infection in CMV-Seropositive Kidney Transplant Recipients: Impact of Pretransplant CMV-Specific Humoral Immunity
por: Kirisri, Similan, et al.
Publicado: (2021) -
604 Risk Factors for Cytomegalovirus (CMV) Reactivation in CMV-seropositive Liver Transplant Patients
por: Bruminhent, Jackrapong, et al.
Publicado: (2014) -
Correlation of Cytomegalovirus (CMV) Disease Severity and Mortality With CMV Viral Burden in CMV-Seropositive Donor and CMV-Seronegative Solid Organ Transplant Recipients
por: McBride, Jacqueline M, et al.
Publicado: (2019) -
Effect of ageing on CMV-specific CD8 T cells from CMV seropositive healthy donors
por: Pita-Lopez, María Luisa, et al.
Publicado: (2009)